Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose baclofen for alcohol dependence
NL-OMON41310Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence and alcohol use disorder (AUD) comparing High-dose baclofen with Placebo (2 arms). Primary endpoint: Time to first relapse. Started Dec 2012; status: active, not recruiting.
02
Drugs
baclofen
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NL-OMON41310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41310.